Blog

You are here

Research

Neuroblastoma: Searching for the Achilles Heel of Childhood Cancer

Neuroblastoma, the type of cancer our founder Alex Scott battled, is the most-common extra-cranial solid tumor in childhood. Alex’s Lemonade Stand Foundation (ALSF) has helped power research that is getting us closer to cures every day. Researchers like Dr. John Maris from the Children’s Hospital of Philadelphia (CHOP) and Dr.

Childhood cancer research works! Just ask Taylor, future pediatric oncology nurse.

Taylor, a 21-year-old University of North Alabama student, is studying to become a pediatric oncology nurse. Although she’s only in her first year of nursing courses, Taylor knows exactly what nurses can mean to their patients. Taylor was once a cancer patient herself, relying on the nurses as a support system. 

Decoding Immunotherapy: How this Cutting Edge Treatment is Bringing New Hope in the Fight Against Childhood Cancer

The body’s immune system is robust and powerful—it can reject an entire transplant organ within minutes or hours if the mismatch is too severe. The moment it senses infection, the immune system wakes up and deploys cells to heal the body. 

So, why doesn’t the body attack cancer cells the same way it heals an infection?

Five Things You Need to Know About Childhood Cancer Research

In October, Alex's Lemonade Stand Foundation hosted its third annual Young Investigators Summit, generously sponsored by Northwestern Mutual.  Nearly 50 young scientists who have received ALSF grants attended, shared research, networked and collaborated. This two-day summit is one of the ways ALSF helps spur advances toward cures. These young scientists each presented their research, heard presentations from established researchers and were inspired by the story of a childhood cancer hero.